Angiogenesis and antiangiogenic therapy in hematologic malignancies
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 62 (2) , 105-118
- https://doi.org/10.1016/j.critrevonc.2006.11.006
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Angiogenesis in multiple myelomaPublished by Elsevier ,2006
- Angiogenesis in nodal B cell lymphomas: a high throughput studyJournal of Clinical Pathology, 2006
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administrationWound Repair and Regeneration, 2005
- Tumstatin, the NC1 domain of α3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growthPublished by Elsevier ,2005
- Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivoBlood, 2004
- Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progressionLaboratory Investigation, 2004
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971